A major clinical trial found that one in five people with chronic hepatitis B could control the virus without further ...

Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these ...

The study comes months after the Advisory Committee on Immunization Practices (ACIP) voted in December 2025 to replace its ...

A single hepatitis B injection set off a lasting immune response, and two patients reached a functional cure that held for ...

The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.

Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping ...

The findings supporting bepiroversen were deemed a “historic moment” by physicians and validate a drug that has “clear ...

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers reported Thursday.

GSK said its experimental chronic hepatitis B drug helped nearly one in five patients achieve a ‌functional cure in ...

There is currently no known cure for hepatitis B virus (HBV) infection, and HBV remains a major public health burden in the United States. The US Department of Health and Human Services has ...

California Democratic Rep. Doris Matsui has advanced to the November ballot after facing a reelection challenge from a ...